Fairmount Funds Management Llc Glycomimetics Inc (GLYC) insider trading activity

GLYC Quotes by TradingView

Fairmount Funds Management LLC Transaction History

Date Transaction Value Shares Traded Form
Dec 04 2025
BUY
Open market or private purchase
$18,237,600 $13.41 p/Share
1,360,000

Also insider at

AVTE
Aerovate Therapeutics, Inc. Healthcare
Director
COGT
Cogent Biosciences, Inc. Healthcare
Director
VRDN
Viridian Therapeutics, Inc.\DE Healthcare
Director
MGTA
Magenta Therapeutics, Inc. Healthcare
Director
ABIO
ARCA biopharma, Inc. Healthcare
Director
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
APGE
Apogee Therapeutics, Inc.
Director
ZBIO
Zenas BioPharma, Inc.
Director
FFM

Fairmount Funds Management LLC

Director
Philadelphia, PA

Track Institutional and Insider Activities on GLYC

Follow GLYCOMIMETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLYC shares.

Notify only if

Insider Trading

Get notified when an Glycomimetics Inc insider buys or sells GLYC shares.

Notify only if

News

Receive news related to GLYCOMIMETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLYC